Validation experiment designed to validate causal mechanisms targeting SNCA in Thy1.2-α-synuclein transgenic mice. Primary outcome: microglial response and motor function (wheel-running activity)
A therapeutic intervention study was performed using Thy1.2-α-synuclein mice treated with dexamethasone starting at 5 months of age for 1 month duration. The study assessed the effects of anti-inflammatory treatment on microglial response in the brain and motor function using wheel-running activity tests. Results showed that dexamethasone treatment significantly decreased the microglial response in the brain and promoted functional recovery in motor performance. This experiment demonstrated that inhibiting inflammation can provide beneficial effects on motor phenotypes in an animal model of α-synucleinopathy, supporting the therapeutic potential of anti-inflammatory approaches in Parkinson's disease.
Dexamethasone treatment for 1 month starting at 5 months of age, followed by assessment of brain microglia and wheel-running activity
Reduced microglial response and improved motor function
Significant decrease in microglial response and functional recovery in motor tests
No debates yet
No results recorded yet. Use POST /api/experiments/{id}/results to record a result.